Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters

被引:171
|
作者
Ioannidis, John P. A. [1 ,2 ,3 ]
Axfors, Cathrine [3 ,4 ]
Contopoulos-Ioannidis, Despina G. [5 ]
机构
[1] Stanford Univ, Stanford Prevent Res Ctr, Dept Med, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA 94305 USA
[3] Meta Res Innovat Ctr Stanford METRICS, Stanford, CA USA
[4] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden
[5] Stanford Univ, Div Infect Dis, Dept Pediat, Sch Med, Stanford, CA 94305 USA
关键词
COVID-19; Mortality; Risk; Age; Underlying diseases; BURDEN;
D O I
10.1016/j.envres.2020.109890
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Objective: To provide estimates of the relative rate of COVID-19 death in people <65 years old versus older individuals in the general population, the absolute risk of COVID-19 death at the population level during the first epidemic wave, and the proportion of COVID-19 deaths in non-elderly people without underlying diseases in epicenters of the pandemic. Eligible data: Cross-sectional survey of countries and US states with at least 800 COVID-19 deaths as of April 24, 2020 and with information on the number of deaths in people with age <65. Data were available for 14 countries (Belgium, Canada, France, Germany, India, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, UK) and 13 US states (California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, New Jersey, New York, Pennsylvania). We also examined available data on COVID-19 deaths in people with age <65 and no underlying diseases. Main outcome measures: Proportion of COVID-19 deaths in people <65 years old; relative mortality rate of COVID-19 death in people <65 versus >= 65 years old; absolute risk of COVID-19 death in people <65 and in those >= 80 years old in the general population as of June 17, 2020; absolute COVID-19 mortality rate expressed as equivalent of mortality rate from driving a motor vehicle. Results: Individuals with age <65 account for 4.5-11.2% of all COVID-19 deaths in European countries and Canada, 8.3-22.7% in the US locations, and were the majority in India and Mexico. People <65 years old had 30to 100-fold lower risk of COVID-19 death than those >= 65 years old in 11 European countries and Canada, 16- to 52-fold lower risk in US locations, and less than 10-fold in India and Mexico. The absolute risk of COVID-19 death as of June 17, 2020 for people <65 years old in high-income countries ranged from 10 (Germany) to 349 per million (New Jersey) and it was 5 per million in India and 96 per million in Mexico. The absolute risk of COVID19 death for people >= 80 years old ranged from 0.6 (Florida) to 17.5 per thousand (Connecticut). The COVID-19 mortality rate in people <65 years old during the period of fatalities from the epidemic was equivalent to the mortality rate from driving between 4 and 82 miles per day for 13 countries and 5 states, and was higher (equivalent to the mortality rate from driving 106-483 miles per day) for 8 other states and the UK. People <65 years old without underlying predisposing conditions accounted for only 0.7-3.6% of all COVID-19 deaths in France, Italy, Netherlands, Sweden, Georgia, and New York City and 17.7% in Mexico. Conclusions: People <65 years old have very small risks of COVID-19 death even in pandemic epicenters and deaths for people <65 years without underlying predisposing conditions are remarkably uncommon. Strategies focusing specifically on protecting high-risk elderly individuals should be considered in managing the pandemic.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] COVID-19 lethality in non-elderly individuals in cities with different Human Development Index
    Alves, Joao Guilherme
    Lima, Tiago Pessoa
    TROPICAL DOCTOR, 2021, 51 (01) : 124 - 125
  • [2] Clinical Differences Between Elderly and Non-elderly Patients with COVID-19
    Ucsular, Fatma Demirci
    Karadeniz, Gulistan
    Polat, Gulru
    Ayranci, Aysu
    Yalniz, Enver
    Kazankaya, Fatmanur
    Guldaval, Filiz
    Buyuksirin, Melih
    Anar, Ceyda
    TURKISH THORACIC JOURNAL, 2022, 23 (03): : 238 - 245
  • [3] CLINICAL FEATURES OF ELDERLY AND NON-ELDERLY INPATIENTS WITH COVID-19 PNEUMONIA
    Liu, Xin
    Mao, Yonghui
    Xi, Huan
    Sun, Ying
    Xu, Lengnan
    Chen, Xianguang
    NEPHROLOGY, 2020, 25 : 4 - 4
  • [4] Age-stratified infection fatality rate of COVID-19 in the non-elderly population
    Pezzullo, Angelo Maria
    Axfors, Cathrine
    Contopoulos-Ioannidis, Despina G.
    Apostolatos, Alexandre
    Ioannidis, John P. A.
    ENVIRONMENTAL RESEARCH, 2023, 216
  • [5] Unvaccinated Non-Elderly Adult Population Hospitalized for COVID-19: Risk for Severe Disease and Poor Outcomes
    Jo, Diana
    Sophonsri, Anthony
    Ny, Pamela
    Lou, Mimi
    Nieberg, Paul
    Shriner, Kimberly
    Wong-Beringer, Annie
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2022, 13
  • [6] Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19
    Hedberg, Pontus
    Sotoodeh, Adonis
    Askling, Helena H. H.
    Naucler, Pontus
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (05) : 640 - 652
  • [7] Different characteristics of critical COVID-19 and thinking of treatment strategies in non-elderly and elderly severe adult patients
    Liu, Zhelong
    Wu, Danning
    Han, Xia
    Jiang, Wangyan
    Qiu, Lin
    Tang, Rui
    Yu, Xuefeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [8] Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals - Two randomised, controlled trials
    Noveck, RJ
    Laurent, A
    Kuss, M
    Talwalker, S
    Hubbard, RC
    CLINICAL DRUG INVESTIGATION, 2001, 21 (07) : 465 - 476
  • [9] Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19
    Xu, Donghua
    Qin, Xuebin
    VIRUSES-BASEL, 2024, 16 (09):
  • [10] Difference between elderly and non-elderly patients in using serum lactate level to predict mortality caused by sepsis in the emergency department
    Cheng, Hsien-Hung
    Chen, Fu-Cheng
    Change, Meng-Wei
    Kung, Chia-Te
    Cheng, Chi-Yung
    Tsai, Tsung-Cheng
    Hsiao, Sheng-Yuan
    Su, Chih-Min
    MEDICINE, 2018, 97 (13)